Nasal Vaccine For Covid
- All
- News
- Videos
-
Covid Nasal Vaccine A "Mighty Display Of India's Research: Health Minister
Mansukh Manadaviya said that the world's first intranasal vaccine for Covid-19 iNCOVACC launched is a testimony to the innovative zeal of our scientists and a display of India's research and innovation prowess under the leadership of PM Modi.
-
India Gets Its Own Nasal Vaccine, Booster Costs Rs 800 Per Dose
The company, in December 2022, got the approval for the primary 2-dose schedule, and as a heterologous booster dose.
-
Covid Nasal Vaccine: How To Book It, How Much It Costs
Bharat Biotech's nasal vaccine will cost Rs 800 plus taxes at private hospitals and slots can now be booked on the CoWin's portal, the pharmaceutical major has announced.
-
Nasal Vaccine Available From Today. Where You Can Get It
The government today approved the inclusion of an intranasal Covid vaccine in the vaccination programme as a booster dose for adults. The inclusion comes amid a surge in cases in China and some other countries.
-
Nasal Vaccine From Today, Hospital Drills - Preps In Top Gear: 10 Facts
Mock drills will be conducted at hospitals across the country from Tuesday onwards in view of a spike in Covid cases in some countries, the union health ministry said today, adding that it is preparing fresh guidelines for Christmas and New Year.
-
Bharat Biotech To Launch 1st Nasal Covid Vaccine, No Efficacy Data Released
Bharat Biotech's needle-free intranasal Covid vaccine has been cleared for restricted use in emergency situations for those above the age of 18 years. iNCOVACC will become the first intranasal vaccine in the world.
-
High Hopes For Nasal Covid Vaccines Despite "Disappointing" Trial
Nasal vaccines could still be a powerful future weapon in the fight against Covid-19 despite "disappointing" recent trial results for an AstraZeneca spray, experts say.
-
AstraZeneca Nasal Spray Vaccine For Covid Fizzles In Small, Early Trial
AstraZeneca Plc's ambitions for developing an easier formulation of its Covid-19 vaccine -- one that might help curb contagion as well -- suffered a setback Monday as the nasal spray failed in an early test.
-
New Intranasal Anti-Viral Treatment May Block Covid Transmission: Report
Researchers have developed an intranasal anti-viral treatment for COVID-19 that decreases the amount of SARS-CoV-2 shed from infected animals and limits transmission of the virus.
-
Bharat Biotech's Nasal Vaccine Against Covid-19 Cleared For Use
Union Health Minister Dr Mansukh Mandaviya tweets that it's "a big boost to India's Fight against Covid-19"
-
5-Point Guide To The New Nasal Spray For Covid Cleared By India
A nasal spray to treat adult COVID-19 patients has been launched in India after Mumbai-based developers Glenmark Pharmaceuticals received marketing clearances from the Drugs Controller General of India as part of an accelerated approval process.
-
Nasal Vaccine, World's First DNA Covid Jab To Be Available Soon: PM Modi
Prime Minister Narendra Modi on Saturday said that the nasal vaccine and the world's first DNA vaccine against the COVID-19 will soon be available for the inoculation drive.
-
Bharat Biotech's 1st Nasal Covid Vaccine Gets Phase 2/3 Trial Nod
BBV154, developed by Bharat Biotech, is India's first intranasal vaccine to receive regulatory nod for late-stage clinical trials from the Biotechnology Industry Research Assistance Council's (BIRAC) under the Department of Biotechnology.
-
Nasal Covid Vaccine Candidate In Early Stage Of Development: Centre
An intranasal vaccine candidate (BBV154), being developed by Bharat Biotech, is in early clinical stage of development in India, Minister of State for Health Ashwini Choubey told the Rajya Sabha on Tuesday.
-
Covid Nasal Vaccine A "Mighty Display Of India's Research: Health Minister
Mansukh Manadaviya said that the world's first intranasal vaccine for Covid-19 iNCOVACC launched is a testimony to the innovative zeal of our scientists and a display of India's research and innovation prowess under the leadership of PM Modi.
-
India Gets Its Own Nasal Vaccine, Booster Costs Rs 800 Per Dose
The company, in December 2022, got the approval for the primary 2-dose schedule, and as a heterologous booster dose.
-
Covid Nasal Vaccine: How To Book It, How Much It Costs
Bharat Biotech's nasal vaccine will cost Rs 800 plus taxes at private hospitals and slots can now be booked on the CoWin's portal, the pharmaceutical major has announced.
-
Nasal Vaccine Available From Today. Where You Can Get It
The government today approved the inclusion of an intranasal Covid vaccine in the vaccination programme as a booster dose for adults. The inclusion comes amid a surge in cases in China and some other countries.
-
Nasal Vaccine From Today, Hospital Drills - Preps In Top Gear: 10 Facts
Mock drills will be conducted at hospitals across the country from Tuesday onwards in view of a spike in Covid cases in some countries, the union health ministry said today, adding that it is preparing fresh guidelines for Christmas and New Year.
-
Bharat Biotech To Launch 1st Nasal Covid Vaccine, No Efficacy Data Released
Bharat Biotech's needle-free intranasal Covid vaccine has been cleared for restricted use in emergency situations for those above the age of 18 years. iNCOVACC will become the first intranasal vaccine in the world.
-
High Hopes For Nasal Covid Vaccines Despite "Disappointing" Trial
Nasal vaccines could still be a powerful future weapon in the fight against Covid-19 despite "disappointing" recent trial results for an AstraZeneca spray, experts say.
-
AstraZeneca Nasal Spray Vaccine For Covid Fizzles In Small, Early Trial
AstraZeneca Plc's ambitions for developing an easier formulation of its Covid-19 vaccine -- one that might help curb contagion as well -- suffered a setback Monday as the nasal spray failed in an early test.
-
New Intranasal Anti-Viral Treatment May Block Covid Transmission: Report
Researchers have developed an intranasal anti-viral treatment for COVID-19 that decreases the amount of SARS-CoV-2 shed from infected animals and limits transmission of the virus.
-
Bharat Biotech's Nasal Vaccine Against Covid-19 Cleared For Use
Union Health Minister Dr Mansukh Mandaviya tweets that it's "a big boost to India's Fight against Covid-19"
-
5-Point Guide To The New Nasal Spray For Covid Cleared By India
A nasal spray to treat adult COVID-19 patients has been launched in India after Mumbai-based developers Glenmark Pharmaceuticals received marketing clearances from the Drugs Controller General of India as part of an accelerated approval process.
-
Nasal Vaccine, World's First DNA Covid Jab To Be Available Soon: PM Modi
Prime Minister Narendra Modi on Saturday said that the nasal vaccine and the world's first DNA vaccine against the COVID-19 will soon be available for the inoculation drive.
-
Bharat Biotech's 1st Nasal Covid Vaccine Gets Phase 2/3 Trial Nod
BBV154, developed by Bharat Biotech, is India's first intranasal vaccine to receive regulatory nod for late-stage clinical trials from the Biotechnology Industry Research Assistance Council's (BIRAC) under the Department of Biotechnology.
-
Nasal Covid Vaccine Candidate In Early Stage Of Development: Centre
An intranasal vaccine candidate (BBV154), being developed by Bharat Biotech, is in early clinical stage of development in India, Minister of State for Health Ashwini Choubey told the Rajya Sabha on Tuesday.
